{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:07:09Z","timestamp":1779232029413,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"Comisi\u00f3n Nacional de Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["FONDEF D10E1007"],"award-info":[{"award-number":["FONDEF D10E1007"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chile has high incidence rates of gallbladder cancer globally, particularly among Amerindian women, who also have a high prevalence of gallstones. We examined differences in inflammatory biomarkers between Mapuche and non-Mapuche women from the Chile Biliary Longitudinal Study, a cohort of women with ultrasound-detected gallstones. We randomly selected 200 Mapuche women frequency matched to non-Mapuche women on age and statin use Inflammatory biomarkers were analyzed using a multiplex assay and linear regression to assess associations of a priori markers (CCL20, CXCL10, IL-6, and IL-8) with ethnicity. Novel biomarkers were analyzed using exploratory factor analysis (EFA) and sufficient dimension reduction (SDR) to identify correlated marker groups, followed by linear regression to examine their association with ethnicity. The mean values of IL-8 were higher in Mapuche than non-Mapuche women (<jats:italic>P<\/jats:italic>\u2009=\u20090.04), while CCL20, CXCL10, and IL-6 did not differ significantly by ethnicity. EFA revealed two marker groups associated with ethnicity (<jats:italic>P<\/jats:italic>\u2009=\u20090.03 and <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). SDR analysis confirmed correlation between the biomarkers and ethnicity. We found higher IL-8 levels among Mapuche than non-Mapuche women. Novel inflammatory biomarkers were correlated with ethnicity and should be studied further for their role in gallbladder disease. These findings may elucidate underlying ethnic disparities in gallstones and carcinogenesis among Amerindians.<\/jats:p>","DOI":"10.1038\/s41598-021-83300-2","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T11:03:58Z","timestamp":1613041438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer"],"prefix":"10.1038","volume":"11","author":[{"given":"Sarah S.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Van De Wyngard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paz","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ligia A.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon H.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.","family":"Verdugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Y\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Tobar-Calfucoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Retamales-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catterina","family":"Ferreccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Koshiol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"10","key":"83300_CR1","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1002\/ijc.25421","volume":"127","author":"E Bertran","year":"2010","unstructured":"Bertran, E., Heise, K., Andia, M. E. & Ferreccio, C. Gallbladder cancer: Incidence and survival in a high-risk area of Chile. Int J Cancer. 127(10), 2446\u20132454 (2010).","journal-title":"Int J Cancer."},{"key":"83300_CR2","volume-title":"SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988\u20132001","author":"C Key","year":"2007","unstructured":"Key, C. & Meisner, A. L. W. Cancers of the liver and biliary tract. In SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988\u20132001 (eds Ries, L. A. G. et al.) (NIH, Bethesda, 2007)."},{"issue":"2","key":"83300_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton, L. M. & Shaffer, E. A. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver 6(2), 172\u2013187 (2012).","journal-title":"Gut Liver"},{"key":"83300_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/ijc.32863","volume":"147","author":"A Miranda-Filho","year":"2020","unstructured":"Miranda-Filho, A. et al. Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends. Int. J. Cancer 147, 978\u2013989 (2020).","journal-title":"Int. J. Cancer"},{"key":"83300_CR5","first-page":"704","volume":"10","author":"L Villanueva","year":"2016","unstructured":"Villanueva, L. Cancer of the gallbladder-Chilean statistics. Ecancermedicalscience 10, 704\u2013704 (2016).","journal-title":"Ecancermedicalscience"},{"issue":"5","key":"83300_CR6","doi-asserted-by":"publisher","first-page":"e1006756","DOI":"10.1371\/journal.pgen.1006756","volume":"13","author":"J Lorenzo Bermejo","year":"2017","unstructured":"Lorenzo Bermejo, J. et al. Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile. PLoS Genet. 13(5), e1006756 (2017).","journal-title":"PLoS Genet."},{"issue":"2","key":"83300_CR7","first-page":"245","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza, J. A. et al. The inflammatory inception of gallbladder cancer. Biochim. Biophys. Acta 1865(2), 245\u2013254 (2016).","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"83300_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1186\/s12885-018-4575-3","volume":"18","author":"JM Nemunaitis","year":"2018","unstructured":"Nemunaitis, J. M. et al. Gallbladder cancer: Review of a rare orphan gastrointestinal cancer with a focus on populations of New Mexico. BMC Cancer. 18(1), 665 (2018).","journal-title":"BMC Cancer."},{"issue":"5","key":"83300_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/diagnostics10050338","volume":"10","author":"K Jayant","year":"2020","unstructured":"Jayant, K., Habib, N., Huang, K. W., Warwick, J. & Arasaradnam, R. Recent advances: The imbalance of immune cells and cytokines in the pathogenesis of hepatocellular carcinoma. Diagnostics (Basel) 10(5), 338 (2020).","journal-title":"Diagnostics (Basel)"},{"key":"83300_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cyto.2016.05.003","volume":"83","author":"J Koshiol","year":"2016","unstructured":"Koshiol, J. et al. Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies. Cytokine 83, 217\u2013225 (2016).","journal-title":"Cytokine"},{"issue":"1","key":"83300_CR11","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1038\/s41598-018-23848-8","volume":"8","author":"Z Liu","year":"2018","unstructured":"Liu, Z. et al. Circulating levels of inflammatory proteins and survival in patients with gallbladder cancer. Sci. Rep. 8(1), 5671 (2018).","journal-title":"Sci. Rep."},{"key":"83300_CR12","doi-asserted-by":"crossref","unstructured":"Koshiol, J., Van De Wyngard, V., McGee E. E. et al. The Chile biliary longitudinal study (Chile BiLS): A Gallstone Cohort. Am. J. Epidemiol. 190(2), 196\u2013206 (2020).","DOI":"10.1093\/aje\/kwaa199"},{"issue":"1","key":"83300_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40659-020-00284-5","volume":"53","author":"RA Verdugo","year":"2020","unstructured":"Verdugo, R. A. et al. Development of a small panel of SNPs to infer ancestry in Chileans that distinguishes Aymara and Mapuche components. Biol. Res. 53(1), 15 (2020).","journal-title":"Biol. Res."},{"key":"83300_CR14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1186\/1471-2164-12-622","volume":"12","author":"L Ding","year":"2011","unstructured":"Ding, L. et al. Comparison of measures of marker informativeness for ancestry and admixture mapping. BMC Genomics 12, 622\u2013622 (2011).","journal-title":"BMC Genomics"},{"issue":"21 Suppl 1","key":"83300_CR15","first-page":"II18","volume":"109","author":"U Schonbeck","year":"2004","unstructured":"Schonbeck, U. & Libby, P. Inflammation, immunity, and HMG-CoA reductase inhibitors: Statins as antiinflammatory agents?. Circulation 109(21 Suppl 1), II18-26 (2004).","journal-title":"Circulation"},{"issue":"18","key":"83300_CR16","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1001\/jama.2009.1601","volume":"302","author":"M Bodmer","year":"2009","unstructured":"Bodmer, M., Brauchli, Y. B., Krahenbuhl, S., Jick, S. S. & Meier, C. R. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA 302(18), 2001\u20132007 (2009).","journal-title":"JAMA"},{"issue":"8","key":"83300_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1136\/gutjnl-2018-317504","volume":"68","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink. Gut 68(8), 1458\u20131464 (2019).","journal-title":"Gut"},{"issue":"4","key":"83300_CR18","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson, E. et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE 9(4), e95192 (2014).","journal-title":"PLoS ONE"},{"issue":"1","key":"83300_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman, K. J. No adjustments are needed for multiple comparisons. Epidemiology (Cambridge, Mass) 1(1), 43\u201346 (1990).","journal-title":"Epidemiology (Cambridge, Mass)"},{"issue":"1","key":"83300_CR20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/biom.12556","volume":"73","author":"D Tomassi","year":"2017","unstructured":"Tomassi, D., Forzani, L., Bura, E. & Pfeiffer, R. Sufficient dimension reduction for censored predictors. Biometrics 73(1), 220\u2013231 (2017).","journal-title":"Biometrics"},{"issue":"2","key":"83300_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2015.06.017","volume":"379","author":"J Ehling","year":"2016","unstructured":"Ehling, J. & Tacke, F. Role of chemokine pathways in hepatobiliary cancer. Cancer Lett. 379(2), 173\u2013183 (2016).","journal-title":"Cancer Lett."},{"issue":"16","key":"83300_CR22","first-page":"5996","volume":"9","author":"Y Ren","year":"2003","unstructured":"Ren, Y. et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma. Correl. Clinicopathol. Features Prognosis 9(16), 5996\u20136001 (2003).","journal-title":"Correl. Clinicopathol. Features Prognosis"},{"issue":"3","key":"83300_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/gutjnl-2011-300509","volume":"61","author":"V Chew","year":"2012","unstructured":"Chew, V. et al. Chemokine-driven lymphocyte infiltration: An early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 61(3), 427\u2013438 (2012).","journal-title":"Gut"},{"issue":"1","key":"83300_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6(1), 24\u201337 (2006).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"83300_CR25","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.3892\/mmr.2014.3143","volume":"11","author":"M Zhang","year":"2015","unstructured":"Zhang, M. et al. Expression of interleukin-6 is associated with epithelial-mesenchymal transition and survival rates in gallbladder cancer. Mol. Med. Rep. 11(5), 3539\u20133546 (2015).","journal-title":"Mol. Med. Rep."},{"issue":"Suppl 2","key":"83300_CR26","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay, C. Interleukin-6 and chronic inflammation. Arthritis Res. Therapy 8(Suppl 2), S3 (2006).","journal-title":"Arthritis Res. Therapy"},{"key":"83300_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.canep.2018.03.004","volume":"54","author":"J Koshiol","year":"2018","unstructured":"Koshiol, J. et al. Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions. Cancer Epidemiol. 54, 25\u201330 (2018).","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"83300_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ajpath.2014.08.025","volume":"185","author":"P Gurung","year":"2015","unstructured":"Gurung, P. & Kanneganti, T.-D. Novel roles for caspase-8 in IL-1\u03b2 and inflammasome regulation. Am. J. Pathol. 185(1), 17\u201325 (2015).","journal-title":"Am. J. Pathol."},{"issue":"6651","key":"83300_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/39335","volume":"389","author":"KT Uysal","year":"1997","unstructured":"Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-\u03b1 function. Nature 389(6651), 610\u2013614 (1997).","journal-title":"Nature"},{"issue":"1","key":"83300_CR30","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1038\/s41598-017-05932-7","volume":"7","author":"V Zoller","year":"2017","unstructured":"Zoller, V. et al. Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes. Sci. Rep. 7(1), 5691 (2017).","journal-title":"Sci. Rep."},{"issue":"1","key":"83300_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ni.1819","volume":"11","author":"P-H Tseng","year":"2010","unstructured":"Tseng, P.-H. et al. Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11(1), 70 (2010).","journal-title":"Nat. Immunol."},{"issue":"1","key":"83300_CR32","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41598-018-35852-z","volume":"9","author":"BI Bustos","year":"2019","unstructured":"Bustos, B. I. et al. Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestry. Sci. Rep. 9(1), 772 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"83300_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/hep-2017-0008","volume":"4","author":"PL Jansen","year":"2017","unstructured":"Jansen, P. L. Fibroblast growth factor 19, a double-edged sword. Hepat. Oncol. 4(1), 1\u20134 (2017).","journal-title":"Hepat. Oncol."},{"issue":"31","key":"83300_CR34","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1038\/sj.onc.1205591","volume":"21","author":"K Taniguchi","year":"2002","unstructured":"Taniguchi, K. et al. Mutational spectrum of \u03b2-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 21(31), 4863\u20134871 (2002).","journal-title":"Oncogene"},{"key":"83300_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-7-12","volume":"7","author":"A Riehl","year":"2009","unstructured":"Riehl, A., N\u00e9meth, J., Angel, P. & Hess, J. The receptor RAGE: Bridging inflammation and cancer. Cell Commun. Signal. 7, 12\u201312 (2009).","journal-title":"Cell Commun. Signal."},{"issue":"11","key":"83300_CR36","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1210\/jc.2003-032223","volume":"89","author":"A Kosaki","year":"2004","unstructured":"Kosaki, A. et al. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 89(11), 5423\u20135428 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"83300_CR37","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1161\/ATVBAHA.114.304306","volume":"34","author":"S Ligthart","year":"2014","unstructured":"Ligthart, S. et al. EN-RAGE. Arterioscler. Thromb. Vasc. Biol. 34(12), 2695\u20132699 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"83300_CR38","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cyto.2005.01.018","volume":"30","author":"J Hwang","year":"2005","unstructured":"Hwang, J. et al. Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30(5), 254\u2013263 (2005).","journal-title":"Cytokine"},{"issue":"3","key":"83300_CR39","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3892\/or.2017.5798","volume":"38","author":"XL Yang","year":"2017","unstructured":"Yang, X. L., Liu, K. Y., Lin, F. J., Shi, H. M. & Ou, Z. L. CCL28 promotes breast cancer growth and metastasis through MAPK-mediated cellular anti-apoptosis and pro-metastasis. Oncol. Rep. 38(3), 1393\u20131401 (2017).","journal-title":"Oncol. Rep."},{"issue":"11","key":"83300_CR40","first-page":"5031","volume":"9","author":"L Wang","year":"2017","unstructured":"Wang, L. et al. Delta\/notch-like epidermal growth factor-related receptor (DNER) orchestrates stemness and cancer progression in prostate cancer. Am. J. Transl. Res. 9(11), 5031\u20135039 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"83300_CR41","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molmet.2018.03.002","volume":"13","author":"G Singhal","year":"2018","unstructured":"Singhal, G. et al. Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet. Mol. Metab. 13, 56\u201366 (2018).","journal-title":"Mol. Metab."},{"issue":"3","key":"83300_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1101\/gad.1874010","volume":"24","author":"V Gocheva","year":"2010","unstructured":"Gocheva, V. et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 24(3), 241\u2013255 (2010).","journal-title":"Genes Dev."},{"key":"83300_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharmthera.2017.08.008","volume":"183","author":"SM Davis","year":"2018","unstructured":"Davis, S. M. & Pennypacker, K. R. The role of the leukemia inhibitory factor receptor in neuroprotective signaling. Pharmacol. Ther. 183, 50\u201357 (2018).","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"83300_CR44","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1600-0625.2009.00901.x","volume":"18","author":"S Boyd","year":"2009","unstructured":"Boyd, S. et al. MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer. Exp. Dermatol. 18(12), 1044\u20131052 (2009).","journal-title":"Exp. Dermatol."},{"issue":"21","key":"83300_CR45","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.18632\/oncotarget.26699","volume":"10","author":"K Tawara","year":"2019","unstructured":"Tawara, K. et al. HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: Synergistic induction of IL-6 secretion by OSM and IL-1\u03b2. Oncotarget 10(21), 2068\u20132085 (2019).","journal-title":"Oncotarget"},{"issue":"1","key":"83300_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2009.04113.x","volume":"1155","author":"JR Pasqualini","year":"2009","unstructured":"Pasqualini, J. R. Estrogen sulfotransferases in breast and endometrial cancers. Ann. N. Y. Acad. Sci. 1155(1), 88\u201398 (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"83300_CR47","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ijc.32763","volume":"147","author":"J Aversa","year":"2020","unstructured":"Aversa, J. et al. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: A case\u2013cohort study in Japan. Int. J. Cancer 147, 686\u2013691 (2020).","journal-title":"Int. J. Cancer"},{"issue":"7","key":"83300_CR48","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.189.7.1025","volume":"189","author":"MF Bachmann","year":"1999","unstructured":"Bachmann, M. F. et al. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation. J. Exp. Med. 189(7), 1025\u20131031 (1999).","journal-title":"J. Exp. Med."},{"issue":"1","key":"83300_CR49","first-page":"15","volume":"1","author":"S-H Park","year":"2012","unstructured":"Park, S.-H. et al. SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis. Transl. Cancer Res. 1(1), 15\u201321 (2012).","journal-title":"Transl. Cancer Res."},{"issue":"4","key":"83300_CR50","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/1759-7714.12196","volume":"6","author":"L Li","year":"2015","unstructured":"Li, L. et al. Overexpression of eukaryotic translation initiation factor 4E-binding protein 1 induces the alteration of immune status in H1299 lung cancer cells. Thorac Cancer 6(4), 427\u2013432 (2015).","journal-title":"Thorac Cancer"},{"issue":"9954","key":"83300_CR51","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/S0140-6736(14)61603-2","volume":"384","author":"AD Napier","year":"2014","unstructured":"Napier, A. D. et al. Culture and health. Lancet (London, England). 384(9954), 1607\u20131639 (2014).","journal-title":"Lancet (London, England)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83300-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:39:04Z","timestamp":1670038744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-83300-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["83300"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-83300-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"21 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3686"}}